156 related articles for article (PubMed ID: 6195645)
1. A guide to interferon for patients and nurses.
Farris JS; Mayer D
Oncol Nurs Forum; 1983; 10(4):65-8. PubMed ID: 6195645
[No Abstract] [Full Text] [Related]
2. Interferon: current status.
Mayer DK; Smalley RV
Oncol Nurs Forum; 1983; 10(4):14-9. PubMed ID: 6195644
[No Abstract] [Full Text] [Related]
3. [Anti-tumor effects of interferon (author's transl)].
Sun Y
Zhonghua Yi Xue Za Zhi; 1981 Sep; 61(9):556-8. PubMed ID: 6176299
[No Abstract] [Full Text] [Related]
4. [Interferon--the prospects and problems of its use in therapeutic and oncological practice].
Poverennyĭ AM
Med Radiol (Mosk); 1983 Jun; 28(6):67-71. PubMed ID: 6191171
[No Abstract] [Full Text] [Related]
5. Interferons and cancer: how the promise is being kept.
Borden EC
Interferon; 1983; 5():43-83. PubMed ID: 6202643
[No Abstract] [Full Text] [Related]
6. [Interferon: effective but with specific toxicity?].
Dtsch Med Wochenschr; 1981 Jun; 106(26):854-5. PubMed ID: 6165540
[No Abstract] [Full Text] [Related]
7. Treating patients with melanoma with interferon.
Cook J; Zitelli JA
Arch Dermatol; 1997 Mar; 133(3):387-9. PubMed ID: 9080905
[No Abstract] [Full Text] [Related]
8. Model allows nurses to prioritize patient teaching for chemotherapy.
Wintermeyer-Pingle S; Estes J; Cimprich B; Marciniak K
Oncol Nurs Forum; 1997 Apr; 24(3):456-7. PubMed ID: 9127356
[No Abstract] [Full Text] [Related]
9. Adjuvant interferon in melanoma - a resurrection?
Middleton MR; Thatcher N
Br J Cancer; 2001 May; 84(9):1141-2. PubMed ID: 11336461
[No Abstract] [Full Text] [Related]
10. Interferons and their antitumor properties.
Platanias LC
J Interferon Cytokine Res; 2013 Apr; 33(4):143-4. PubMed ID: 23570379
[No Abstract] [Full Text] [Related]
11. Use of interferon in multiple sclerosis.
McFarlin DE
Ann Neurol; 1985 Oct; 18(4):432-3. PubMed ID: 2416264
[No Abstract] [Full Text] [Related]
12. Interferons and osteosarcoma.
Strander H
Cytokine Growth Factor Rev; 2007; 18(5-6):373-80. PubMed ID: 17683971
[TBL] [Abstract][Full Text] [Related]
13. Interferon induced severe digital ischaemia in chronic myeloid leukaemia--successful treatment using ketanserin.
Sachithanandan A; Cuthbert RJ; Barros d'Sa AA
Eur J Vasc Endovasc Surg; 2001 Nov; 22(5):474-6. PubMed ID: 11735190
[No Abstract] [Full Text] [Related]
14. Diverging opinions on interferon therapy for melanoma.
Winn RJ
J Natl Compr Canc Netw; 2004 Jan; 2(1):1. PubMed ID: 19777689
[No Abstract] [Full Text] [Related]
15. Adjuvant interferon for hepatocellular carcinoma.
Okada S; Sato T; Yamamoto S
Hepatology; 2001 Feb; 33(2):481-2. PubMed ID: 11172357
[No Abstract] [Full Text] [Related]
16. [Is treatment with interferon already possible?].
Mikołajski K
Pol Tyg Lek; 1979 Nov; 34(46):1809-11. PubMed ID: 94668
[No Abstract] [Full Text] [Related]
17. Why do so many cancer patients fail to respond to interferon therapy?
Einhorn S; Grander D
J Interferon Cytokine Res; 1996 Apr; 16(4):275-81. PubMed ID: 9162520
[TBL] [Abstract][Full Text] [Related]
18. Interferon therapy.
Alexander MC
NITA; 1987; 10(1):40-2. PubMed ID: 2434885
[No Abstract] [Full Text] [Related]
19. Interferon. Clinical uses and nursing implications.
Jordan K
J Intraven Nurs; 1990; 13(6):388-91. PubMed ID: 1700813
[TBL] [Abstract][Full Text] [Related]
20. Interferons as anticancer agents.
Brodsky I; Hubbell HR
Am Fam Physician; 1984 Jun; 29(6):246-8. PubMed ID: 6203394
[No Abstract] [Full Text] [Related]
[Next] [New Search]
